BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18070019)

  • 1. Pamidronate as a treatment option in calciphylaxis.
    da Costa JB; da Costa AG; Gomes MM
    J Eur Acad Dermatol Venereol; 2008 Sep; 22(9):1128-30. PubMed ID: 18070019
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of calciphylaxis with pamidronate.
    Schliep S; Schuler G; Kiesewetter F
    Eur J Dermatol; 2008; 18(5):554-6. PubMed ID: 18693159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure.
    Monney P; Nguyen QV; Perroud H; Descombes E
    Nephrol Dial Transplant; 2004 Aug; 19(8):2130-2. PubMed ID: 15252173
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of calciphylaxis with pamidronate.
    Hooman N; Naghshi-Zadiyan R; Mehrazma M; Jahangiri F
    Iran J Kidney Dis; 2015 Jan; 9(1):67-70. PubMed ID: 25599740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treating distal calciphylaxis with therapy associated with sevelamer and bisphosphonates].
    León LR
    Nefrologia; 2009; 29(1):92-3. PubMed ID: 19240787
    [No Abstract]   [Full Text] [Related]  

  • 6. What is the role of using sodium thiosulfate or bisphosphonates in the treatment for calciphylaxis?
    Ross EA
    Semin Dial; 2011; 24(4):434-6. PubMed ID: 21851407
    [No Abstract]   [Full Text] [Related]  

  • 7. Nonuraemic cutaneous calciphylaxis: our experience with a challenging disease.
    Neves JM; Cabete J; Fernandes C
    Clin Exp Dermatol; 2020 Aug; 45(6):745-746. PubMed ID: 32304580
    [No Abstract]   [Full Text] [Related]  

  • 8. Nonuraemic calciphylaxis: response to treatment with pamidronate and negative pressure therapy.
    Lorriaux A; Chaby G; Dhaille F; Dadban A; Arnault JP; Dhillies AS; Lombart F; Chatelain D; Lok C
    Clin Exp Dermatol; 2015 Jan; 40(1):52-5. PubMed ID: 25476249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of sodium thiosulfate in the treatment of calciphylaxis.
    Musso CG; Enz P; Vidal F; Gelman R; Lizarraga A; Giuseppe LD; Kowalczuk A; Garfi L; Galimberti R; Algranati L
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1065-8. PubMed ID: 19861872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calciphylaxis responding to sodium thiosulfate therapy.
    Baker BL; Fitzgibbons CA; Buescher LS
    Arch Dermatol; 2007 Feb; 143(2):269-70. PubMed ID: 17310015
    [No Abstract]   [Full Text] [Related]  

  • 11. Complete resolution of recurrent calciphylaxis with long-term intravenous sodium thiosulfate.
    Subramaniam K; Wallace H; Sinniah R; Saker B
    Australas J Dermatol; 2008 Feb; 49(1):30-4. PubMed ID: 18186845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calciphylaxis induced by acquired protein S deficiency in a patient with multiple myeloma - effective treatment with low-molecular-weight heparin.
    Kerk N; Meyer V; Goerge T
    J Dtsch Dermatol Ges; 2012 Jul; 10(7):518-9. PubMed ID: 22551348
    [No Abstract]   [Full Text] [Related]  

  • 13. Calciphylaxis and the cardiometabolic syndrome.
    Hayden MR; Kolb LG; Khanna R
    J Cardiometab Syndr; 2006; 1(1):76-9. PubMed ID: 17675891
    [No Abstract]   [Full Text] [Related]  

  • 14. Sodium thiosulfate as first-line treatment for calciphylaxis.
    Ackermann F; Levy A; Daugas E; Schartz N; Riaux A; Derancourt C; Urena P; Lebbé C
    Arch Dermatol; 2007 Oct; 143(10):1336-7; author reply 1338. PubMed ID: 17938357
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of various diphosphonates on a rat model of cardiac calciphylaxis.
    Rosenblum IY; Black HE; Ferrell JF
    Calcif Tissue Res; 1977 Jun; 23(2):151-9. PubMed ID: 890553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic calciphylaxis.
    Suryadevara M; Schurman SJ; Landas SK; Philip A; Gerlach CB; Tavares T; Souid AK
    Pediatr Blood Cancer; 2008 Oct; 51(4):548-50. PubMed ID: 18491373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demographics, Comorbid Conditions, and Outcomes of Patients With Nonuremic Calciphylaxis.
    Altman K; Shinohara M
    JAMA Dermatol; 2019 Feb; 155(2):251-252. PubMed ID: 30601879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cutaneous expression of vitamin K-dependent and other osteogenic proteins in calciphylaxis stratified by clinical features and warfarin use: A case control study.
    Tian F; Patterson AT; Davick JJ; Ing SW; Kaffenberger BH; Gru AA
    J Am Acad Dermatol; 2016 Oct; 75(4):840-842.e1. PubMed ID: 27646745
    [No Abstract]   [Full Text] [Related]  

  • 19. Calciphylaxis of both proximal and distal distribution.
    Al-Hwiesh AK
    Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):82-6. PubMed ID: 18087130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three cases of penile calciphylaxis: diagnosis, treatment strategies, and the role of sodium thiosulfate.
    O'Neil B; Southwick AW
    Urology; 2012 Jul; 80(1):5-8. PubMed ID: 22748863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.